Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
Línea
Nuclear Medicine
Sublínea
SPECT Radiopharmaceuticals
NEUROBAC
Línea
Nuclear Medicine
Sublínea
SPECT Radiopharmaceuticals
NEUROBAC
Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest...